Trials / Completed
CompletedNCT00986024
Resistance and/or Endurance Training, What is Most Effective in Prevention of Cardiovascular Diseases?
Strength Training Versus Aerobic Interval Training to Modify Risk Factors of the Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the present study was to evaluate the effects of aerobic interval training versus strength training or a combination of these regimes on factors comprising the metabolic syndrome in order to find the most effective exercise regime for patients with metabolic syndrome.
Detailed description
In the Western world, approximately 25% of young to middle-aged adults have metabolic syndrome. There seem to be a strong age-dependence in the prevalence of the metabolic syndrome, but the incidence rises rapidly within adolescents and middle-aged groups and follows the development of obesity in the general population. Metabolic syndrome confers an increased risk of coronary heart disease, cardiovascular disease, and premature death; therefore, effective and affordable strategies to combat the syndrome would be of great individual and social importance. Despite the general agreement that moderate-intensity physical activity for a minimum of 30 min five days per week or vigorous-intensity aerobic physical activity for a minimum of 20 min three days a week promote and maintain health, the optimal training regime to treat metabolic syndrome and its associated cardiovascular abnormalities remains uncertain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | aerobic exercise | carried out 3 times per week for 12 weeks |
| BEHAVIORAL | strength training | carried out 3 times per week for 12 weeks |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2009-09-29
- Last updated
- 2012-12-13
Source: ClinicalTrials.gov record NCT00986024. Inclusion in this directory is not an endorsement.